Skip to content
10-Q

Quarterly Report

Flexion Therapeutics, Inc.

0001564590-21-026980

← back to feed
Filed
May 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 1, 2021 49.94M sh
Capex Q1 2021 · Mar 31, 2021 $801K
Capex Q1 2021 · Mar 31, 2020 $3.24M
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$18.47M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$28.2M
Long Term Debt Q1 2021 · Mar 31, 2021 $39.76M
Long Term Debt Q1 2021 · Dec 31, 2020 $44.11M
Short Term Debt Q1 2021 · Mar 31, 2021 $18.33M
Short Term Debt Q1 2021 · Dec 31, 2020 $16.81M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $98.71M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $107.7M
Stockholders Equity Q1 2021 · Mar 31, 2021 −$38.87M
Stockholders Equity Q1 2021 · Dec 31, 2020 −$16.66M
Stockholders Equity Q1 2021 · Mar 31, 2020 −$52.31M
Stockholders Equity Q1 2021 · Dec 31, 2019 −$20.11M
Current Liabilities Q1 2021 · Mar 31, 2021 $57.98M
Current Liabilities Q1 2021 · Dec 31, 2020 $55.27M
Total Liabilities Q1 2021 · Mar 31, 2021 $269.25M
Total Liabilities Q1 2021 · Dec 31, 2020 $268.59M
Current Assets Q1 2021 · Mar 31, 2021 $204.62M
Current Assets Q1 2021 · Dec 31, 2020 $225.81M
Total Assets Q1 2021 · Mar 31, 2021 $230.38M
Total Assets Q1 2021 · Dec 31, 2020 $251.93M
Sga Expense Q1 2021 · Mar 31, 2021 $27.6M
Sga Expense Q1 2021 · Mar 31, 2020 $29.3M
Rd Expense Q1 2021 · Mar 31, 2021 $14.05M
Rd Expense Q1 2021 · Mar 31, 2020 $21.13M
Net Income Q1 2021 · Mar 31, 2021 −$28.56M
Net Income Q1 2021 · Mar 31, 2020 −$36.8M
Operating Income Q1 2021 · Mar 31, 2021 −$23.14M
Operating Income Q1 2021 · Mar 31, 2020 −$32.58M
Cost Of Revenue Q1 2021 · Mar 31, 2021 $6.09M
Cost Of Revenue Q1 2021 · Mar 31, 2020 $2.28M
Revenue Q1 2021 · Mar 31, 2021 $24.59M
Revenue Q1 2021 · Mar 31, 2020 $20.13M